among 224 evaluable cases , the timentin associated wound infection rate ( 0.7 % ) , nonwound infectious morbidity ( 8.8 % ) , adverse reactions ( 1.9 % ) , and total costs ( $ 14.15 ) were not statistically different than that of the control drug .
C0043241
wound infection
C0009450
infectious